Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB1/CB2 receptors

This publication has 38 references indexed in Scilit:

• The Activity of Anandamide at Vanilloid VR1 Receptors Requires Facilitated Transport across the Cell Membrane and Is Limited by Intracellular Metabolism
  Journal of Biological Chemistry, 2001
• Structure‐activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens
  British Journal of Pharmacology, 2001
• Endocannabinoids control spasticity in a multiple sclerosis model
  The FASEB Journal, 2000
• Levels, Metabolism, and Pharmacological Activity of Anandamide in CB₁ Cannabinoid Receptor Knockout Mice
  Journal of Neurochemistry, 2000
• The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
  British Journal of Pharmacology, 2000
• Unsaturated Long-Chain N-Acyl-vanillyl-amides (N-AVAMs): Vanilloid Receptor Ligands That Inhibit Anandamide-Facilitated Transport and Bind to CB1 Cannabinoid Receptors
  Biochemical and Biophysical Research Communications, 1999
• Intravesical Instillation of Capsaicin in Urology: A Review of the Literature
  European Urology, 1999
• Optimal scoring strategies and weights for the formalin test in rats
  Pain, 1997
• The formalin test: an evaluation of the method
  PAIN®, 1992
• The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats
  Pain, 1977